Home
/
LIFECORE BIOMEDICAL, INC. \DE\
/
Financials
/
Quarterly
LIFECORE BIOMEDICAL, INC. \DE\ — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that LIFECORE BIOMEDICAL, INC. \DE\ filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2014
Feb 23, 2014
$126.38M
Mar 28, 2014
Q2
2014
Nov 24, 2013
$120.03M
Jan 3, 2014
Q1
2014
Aug 25, 2013
$109.48M
Sep 26, 2013
Q3
2014
Feb 24, 2013
$117.87M
Mar 28, 2014
Q2
2014
Nov 25, 2012
$114.65M
Jan 3, 2014
Q1
2014
Aug 26, 2012
$102.07M
Sep 26, 2013
Q3
2013
Feb 26, 2012
$80.06M
Apr 4, 2013
Q2
2013
Nov 27, 2011
$81.57M
Jan 4, 2013
Q1
2013
Aug 28, 2011
$73.30M
Jan 2, 2013
Q3
2012
Feb 27, 2011
$73.51M
Mar 28, 2012
Q2
2012
Nov 28, 2010
$70.17M
Jan 5, 2012
Q1
2012
Aug 29, 2010
$64.95M
Oct 5, 2011
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Feb 25, 2018
$149.32M
Apr 5, 2018
Q2
2018
Nov 26, 2017
$136.46M
Jan 5, 2018
Q1
2018
Aug 27, 2017
$123.36M
Sep 28, 2017
Q3
2018
Feb 26, 2017
$136.57M
Apr 5, 2018
Q2
2018
Nov 27, 2016
$135.87M
Jan 5, 2018
Q1
2018
Aug 28, 2016
$132.39M
Sep 28, 2017
Q3
2017
Feb 28, 2016
$129.99M
Apr 7, 2017
Q2
2017
Nov 29, 2015
$140.44M
Jan 5, 2017
Q1
2017
Aug 30, 2015
$135.36M
Sep 29, 2016
Q3
2016
Mar 1, 2015
$138.53M
Mar 30, 2016
Q2
2016
Nov 30, 2014
$132.67M
Jan 7, 2016
Q1
2016
Aug 31, 2014
$133.61M
Oct 1, 2015
Q3
2015
Feb 23, 2014
$126.38M
Apr 2, 2015
Q2
2015
Nov 24, 2013
$120.03M
Jan 9, 2015
Q1
2015
Aug 25, 2013
$109.48M
Oct 8, 2014
Q3
2014
Feb 24, 2013
$117.87M
Mar 28, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Sep 30, 2025
($9.99M)
Nov 6, 2025
Q3
2025
Feb 23, 2025
($14.77M)
Apr 3, 2025
Q2
2025
Nov 24, 2024
($6.57M)
Jan 2, 2025
Q1
2026
Aug 25, 2024
($16.23M)
Nov 6, 2025
Q2
2025
Aug 25, 2024
($16.23M)
Jan 2, 2025
Q3
2025
Feb 25, 2024
$15.63M
Apr 3, 2025
Q2
2025
Nov 26, 2023
$14.22M
Jan 2, 2025
Q3
2024
Nov 26, 2023
$14.22M
Aug 9, 2024
Q3
2024
Aug 27, 2023
($10.75M)
Aug 9, 2024
Q1
2025
Aug 27, 2023
($10.75M)
Oct 4, 2024
Q2
2025
Aug 27, 2023
($10.75M)
Jan 2, 2025
Q3
2024
Feb 26, 2023
($36.51M)
Aug 9, 2024
Q2
2024
Nov 27, 2022
($12.81M)
Aug 9, 2024
Q3
2024
Nov 27, 2022
($12.81M)
Aug 9, 2024
Q1
2024
Aug 28, 2022
($10.97M)
Aug 9, 2024
Q3
2024
Aug 28, 2022
($10.97M)
Aug 9, 2024
Q2
2024
Aug 28, 2022
($10.97M)
Aug 9, 2024
Q3
2023
Feb 27, 2022
($13.09M)
Jun 2, 2023
Q2
2023
Nov 28, 2021
($38.44M)
Mar 16, 2023
Q3
2023
Nov 28, 2021
($38.52M)
Jun 2, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Sep 30, 2025
($3.07M)
Nov 6, 2025
Q3
2025
Feb 23, 2025
($9.03M)
Apr 3, 2025
Q2
2025
Nov 24, 2024
($1.96M)
Jan 2, 2025
Q1
2026
Aug 25, 2024
($11.58M)
Nov 6, 2025
Q3
2025
Feb 25, 2024
($895.0K)
Apr 3, 2025
Q2
2025
Nov 26, 2023
($1.48M)
Jan 2, 2025
Q1
2025
Aug 27, 2023
($8.61M)
Oct 4, 2024
Q3
2024
Feb 26, 2023
($6.53M)
Aug 9, 2024
Q2
2024
Nov 27, 2022
($5.35M)
Aug 9, 2024
Q3
2022
Aug 28, 2022
($8.16M)
Oct 7, 2022
Q1
2024
Aug 28, 2022
($3.27M)
Aug 9, 2024
Q3
2023
Feb 27, 2022
($8.57M)
Jun 2, 2023
Q2
2023
Nov 28, 2021
$4.14M
Mar 16, 2023
Q3
2022
Aug 29, 2021
($2.74M)
Oct 7, 2022
Q1
2022
Aug 29, 2021
($2.74M)
Mar 16, 2023
Q3
2022
Feb 28, 2021
$2.44M
Apr 7, 2022
Q2
2022
Nov 29, 2020
($1.47M)
Jan 7, 2022
Q1
2022
Aug 30, 2020
($12.47M)
Oct 5, 2021
Q3
2021
Feb 23, 2020
($15.01M)
Apr 8, 2021
Q2
2021
Nov 24, 2019
($6.04M)
Jan 7, 2021